Health Research Board (HRB)’s Post

Do you have an innovation that is advancing health justice in your system? We’d love to elevate it and share it at our annual health equity summit EQTY 24! Submit your application in the link below before June 5 #healthequity #healthjustice #EQTY24

It was a very enlightening session at the DEAL Fellowship session this afternoon, participating in a lecture on “Implementation Research in Public Health", delivered by Dr. Olayinka Obanewa, Head of Special Duties at the FCTA Health Service and Environment Secretariat. He delved into critical areas of Implementation Research in public health, from general definition (in simple terms), to categories of theories/models/frameworks used in implementation research, methodology, outcomes, and importance of Implementation Research; including how implementation research can be leveraged for evidence-based practice in public health to maximize impact of interventions. While this is not a totally new topic for me, it was good to gain new insights into many grey areas. Here are my key takeaways from the session: -      Implementation research focuses on understanding how to effectively implement and scale up evidence-based interventions, programs, or policies in real-world settings. -      It aims to identify the most effective strategies for overcoming barriers to implementation and ensuring that interventions are delivered as intended. -      It aims to bridge the gap between research and practice to improve the quality and effectiveness of health services. -      It is a transdisciplinary venture and a convergence of different research perspectives. It involves economics, policy, organizational researchers, anthropologists, social workers, and most importantly the communities. -      Benefits of Implementation research include: o  Enhance effectiveness of interventions o  Increased efficiency in delivery of services o  Enhanced scalability and sustainability of interventions o  Better understanding of context-specific factors influencing implementation o  Provide opportunity for stakeholder engagement o  More effective use of resources -  Desired outcomes in Implementation research include: o  Implementation Outcomes: like acceptability, adoption, appropriateness, feasibility, fidelity, costs, penetration and sustainability o  Service outcomes: Efficiency, effectiveness, safety, equity, patient centeredness, timeliness o  Patient Outcome: Patient satisfaction, Health status/symptoms Thanks @Dr. Olayinka Obanewa for the insightful session. #PublicHealth   #ImplementationScience   #ImplementationReseach             #DEALFellowship2024  #WestAfricanInstituteofPublicHealth             #AcademyofPublicHealth     

WHO recently convened a global consultation to develop an action plan for strengthening and sustaining clinical research capabilities worldwide. Experts from across sectors came together to provide input, including researchers, funders, ethicists, and policymakers. The goal is to create a comprehensive plan that will guide collaborative efforts to bolster the global clinical trials ecosystem and ensure better health outcomes for all. This is a crucial step towards a more robust and equitable clinical research infrastructure globally. What are some of the major challenges and barriers that need to be addressed to achieve this goal, and how might the action plan seek to overcome them? Let me know your thoughts down below! #WHO #ClinicalResearch #Sustainability #ActionPlan

WHO recently convened a global consultation to develop an action plan for strengthening and sustaining clinical research capabilities worldwide. Experts from across sectors came together to provide input, including researchers, funders, ethicists, and policymakers. The goal is to create a comprehensive plan that will guide collaborative efforts to bolster the global clinical trials ecosystem and ensure better health outcomes for all. This is a crucial step towards a more robust and equitable clinical research infrastructure globally. What are some of the major challenges and barriers that need to be addressed to achieve this goal, and how might the action plan seek to overcome them? Let me know your thoughts down below! #WHO #ClinicalResearch #Sustainability #ActionPlan

The Advanced Research Projects Agency for Health (ARPA-H) supports the development of high-impact research to drive biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone.* ARPA-H’s mission focuses on leveraging research advances for real world impact. ARPA-H advances high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity. ARPA-H awardees are developing entirely new ways to tackle the hardest challenges in health. The ARPA model enables visionary Program Managers to tackle a specific problem, working with a range of performers and a variety of approaches to solve that problem, while incorporating measurement and evaluation throughout the process. Program Managers serve for limited terms to ensure a constant infusion of fresh thinking and new perspectives https://www.nih.gov/arpa-h

Something informative and purposeful to enjoy with your morning coffee - Trinity’s latest white paper on clinical trial diversity. There is so much investment by industry in getting this right, and so many reasons to care. In addition to the intrinsic value of equitable access to innovation: ☀️ Trial results are more generalizable if the trial population reflects the patient population ☀️ Certain HTA agencies are including health equity in their deliberations This paper (link in the comments) explores industry initiatives relating to diversity, the effectiveness of those initiatives, and the likely impact of the FDA guidance to improve diversity. The paper is based on a lit review and interviews with 15 industry leaders. Thank you Monique Marsh, Lisa Bailey, Ph.D. Sebastian Daou,Ari King, MPH, Cassy Ingersoll

Representation and access should always be top of mind when planning clinical trials.

🎉 Reflecting on a Year of Excellence and Innovation! 🎉 As the Head of the Evidence Synthesis Unit at PROPUL Evidence LLP, I am incredibly proud to unveil our Annual Report 2023-2024. This year has been nothing short of transformative for our organization, filled with milestones that reflect our dedication to advancing public health through actionable evidence. 🌟 Key Milestones Achieved: ✅ Delivered impactful evidence synthesis projects, including systematic reviews that informed global health policies. ✅ Strengthened our collaborative networks with renowned organizations like WHO, ICMR, and leading academic institutions. ✅ Garnered prestigious awards and participated in global conferences, showcasing our work on critical global health challenges. What stands out most is the relentless dedication of our team and collaborators who have worked tirelessly to turn research into actionable solutions. 🚀 Looking ahead, we aim to: 🌟 Explore new frontiers in digital health, non-communicable diseases, medical education and health system strengthening. 🌟 Foster deeper collaborations with national and international organizations to amplify the global impact of our work. 📖 Dive into our Annual Report to explore the details of this incredible journey: https://lnkd.in/gaEemTUD To our collaborators, funders, and the incredible PROPUL team—thank you for being part of this journey. Your support and vision inspire us every day to push boundaries and create a healthier, more equitable world. #PublicHealth #EvidenceSynthesis #GlobalHealth #Leadership #ResearchInnovation

While the significance of inclusivity in clinical research cannot be overstated, the path to achieving it is complex. In a recent webinar Sarah Fallon of NIHR Clinical Research Network Greater Manchester highlighted that “using a national site ID service, and allowing all sites to express an interest in bringing the study to their patients, is more inclusive than coming to the UK with pre-selected sites.” To ensure everyone can reap the benefits of research, we need different solutions at different stages of the research process. This is just one example of how we can support commercial sponsors of health research in your quality, diversity, and inclusivity (EDI) endeavours. https://lnkd.in/evY36QKA

Putting Equity into Practice: Patient-Centered Methodologies & Frameworks Building from IVI’s recent health equity reports, "Putting Equity into Practice: Patient-Centered Methodologies & Frameworks" will highlight practical examples of how patients and researchers can partner to incorporate health equity into HTA and explore the research questions that need to come next. Featuring Sneha Dave, Founder & Executive Director, Generation Patient, Anton L.V. Avanceña, PhD, Assistant Professor of Health Outcomes, The University of Texas at Austin College of Pharmacy, and Bellinda King-Kallimanis, PhD, Senior Director of Patient-Focused Research, LUNGevity Foundation. Join the conversation: https://lnkd.in/eeTz8p-n